Logo image of DHT-U.CA

DRI HEALTHCARE TRUST (DHT-U.CA) Stock Price, Forecast & Analysis

Canada - Toronto Stock Exchange - TSX:DHT-U - CA23344H1091

11.51 USD
+0.35 (+3.14%)
Last: 1/8/2026, 7:00:00 PM

DHT-U.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap634.32M
Revenue(TTM)192.69M
Net Income(TTM)-52.23M
Shares55.11M
Float54.60M
52 Week High12.81
52 Week Low7.65
Yearly DividendN/A
Dividend Yield4.57%
EPS(TTM)2.25
PE5.12
Fwd PE4.97
Earnings (Next)03-02 2026-03-02/amc
IPO2021-02-11
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


DHT-U.CA short term performance overview.The bars show the price performance of DHT-U.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20 30

DHT-U.CA long term performance overview.The bars show the price performance of DHT-U.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80 100

The current stock price of DHT-U.CA is 11.51 USD. In the past month the price increased by 12.84%. In the past year, price increased by 0.17%.

DRI HEALTHCARE TRUST / DHT-U Daily stock chart

DHT-U.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
BHC.CA BAUSCH HEALTH COS INC 1.95 3.83B
TLRY.CA TILRAY BRANDS INC N/A 1.48B
CRON.CA CRONOS GROUP INC 24.87 1.43B
DHT-UN.CA DRI HEALTHCARE TRUST 7.14 885.62M
WEED.CA CANOPY GROWTH CORP N/A 637.44M
NGEN.CA NERVGEN PHARMA CORP N/A 584.07M
GUD.CA KNIGHT THERAPEUTICS INC N/A 593.75M
TSND.CA TERRASCEND CORP N/A 412.44M
CPH.CA CIPHER PHARMACEUTICALS INC 16.99 392.22M
ACB.CA AURORA CANNABIS INC N/A 331.14M
HITI.CA HIGH TIDE INC N/A 323.70M
OGI.CA ORGANIGRAM GLOBAL INC N/A 322.39M

DRI HEALTHCARE TRUST / DHT-U.CA FAQ

What does DHT-U do?

DRI Healthcare Trust is an unincorporated open-ended company. The company is headquartered in Toronto, Ontario and currently employs 36 full-time employees. The company went IPO on 2021-02-11. The firm provides capital to universities and research institutions, academic institutions, biotechnology companies and pharmaceutical companies. The company has acquired more than 75 royalties on 45-plus drugs, including Ekterly, Eylea, Keytruda, Orserdu, Remicade, Spinraza, Stelara, Vonjo and Zytiga. Its portfolio includes Empaveli/Syfovre, Eylea I, Eylea II, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Vonjo I, Vonjo II, Xenpozyme, Xolair, Zejula, and other products. Its therapeutic areas include oncology, neurology, ophthalmology, endocrinology, hematology, dermatology, lysosomal storage disorders (LSD) and immunology. The Company’s products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; Vertex Pharmaceuticals; KalVista, Galderma and others.


What is the stock price of DRI HEALTHCARE TRUST today?

The current stock price of DHT-U.CA is 11.51 USD. The price increased by 3.14% in the last trading session.


How is the ChartMill rating for DRI HEALTHCARE TRUST?

DHT-U.CA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


DHT-U.CA Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to DHT-U.CA. When comparing the yearly performance of all stocks, DHT-U.CA turns out to be only a medium performer in the overall market: it outperformed 60.72% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating